2-[11C]Thymidine Positron Emission Tomography Reproducibility in Humans

This publication has 15 references indexed in Scilit:

• 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)
  European Journal Of Cancer, 2003
• 2-[11C]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337.
  JNCI Journal of the National Cancer Institute, 2003
• Phase I Pharmacokinetic and Pharmacodynamic Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors
  Journal of Clinical Oncology, 2003
• Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
  European Journal Of Cancer, 1999
• An automated radiosynthesis of 2-[]thymidine using anhydrous []urea derived from []phosgene
  Applied Radiation and Isotopes, 1999
• FDG uptake, tumour characteristics and response to therapy
  Nuclear Medicine Communications, 1998
• Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
  European Journal of Nuclear Medicine and Molecular Imaging, 1997
• Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.
  Radiology, 1995
• Spectral Analysis of Dynamic PET Studies
  Journal of Cerebral Blood Flow & Metabolism, 1993
• Noninvasive measurement of liver regeneration with positron emission tomography and [2-11C]thymidine
  Gastroenterology, 1991